Prejuvenation: The Clinical Case for Early Aesthetic Intervention

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Prejuvenation is the term that describes an approach where the aim is the prevention or slowdown of the aging process but not its reversal once it has occurred. From a biological standpoint, this concept makes sense because it is always easier to maintain the proper condition of tissues and structures than to reconstruct them later; […]

The post Prejuvenation: The Clinical Case for Early Aesthetic Intervention appeared first on Medical News Bulletin.

How Hospital Humidity Levels Affect Patient Health and Recovery

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Walk down a hospital corridor in January and something about the air feels off. Thinner. A little papery. You’re not imagining it, heating systems strip moisture out of the air as a byproduct of warming it, and nobody really designed around that until fairly recently. Turns out it matters more than the thermostat number ever […]

The post How Hospital Humidity Levels Affect Patient Health and Recovery appeared first on Medical News Bulletin.

Understanding how to use the prescription for pain medicine safely at home

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Pain after an injury or procedure can adversely affect sleep movement and the performance of everyday tasks. When you are prescribed a lot of the time it is easy to focus on just getting relief and not pay attention to the ingredients timing or warnings printed on the bottle. The safe use of medicines begins […]

The post Understanding how to use the prescription for pain medicine safely at home appeared first on Medical News Bulletin.

Red Wine Benefits vs. Risks: What’s the Right Amount to Drink?

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Many people like red wine very much, and they have gotten into the habit of drinking red wine. They drink red wine daily, but these people think that there are benefits to drinking red wine; research says so, and those people who do not drink red wine also start drinking red wine because of the […]

The post Red Wine Benefits vs. Risks: What’s the Right Amount to Drink? appeared first on Medical News Bulletin.

More data tie ultra-processed foods to chronic disease, death

Greater consumption of ultra-processed foods increased the risk for multiple chronic diseases and death, according to a recently published analysis in Family Medicine and Community Health.
The data align with prior studies tying ultra-processed foods (UPFs) adversely to diseases like cancer and mortality.
According to Xiao Liu, MD, PhD, from Duke-NUS Medical School in Singapore, and colleagues, UPF consumption is increasing globally but “uncertainty remains regarding the overall health implications of adult consumption of UPFs, particularly concerning safe consumption levels and potential

FDA approves Juvmo for adults with Parkinson’s disease

The FDA has approved Juvmo, the first and only dopamine agonist for adults with Parkinson’s disease designed to selectively target D1/D5 receptors, according to officials with AbbVie.
Juvmo (tavapadon) has been approved as an oral tablet to be taken once daily with or without levodopa therapy, according to a press release.
By targeting D1/D5 receptors, tavapadon offers healthcare providers an alternative to current dopamine agonists that mainly target D2/D3 receptors, according to Roopal Thakkar, MD, executive vice president of research and development with AbbVie.
“People living with

Extended oral antibiotics may not reduce subsequent infection

Results showed extended oral antibiotic therapy may not reduce the risk for subsequent infection after two-stage reimplantation for total knee arthroplasty.
“Future studies or the next steps would be to see if there are selective cohorts or patients who are at higher risk who may benefit from antibiotics,” Billy I. Kim, MD, orthopedic surgery resident at Hospital for Special Surgery, told Healio.
Kim, along with Andrew J. Sama, MD, and colleagues, retrospectively reviewed data from 2,181 patients with infection who underwent two-stage reimplantation for TKA and categorized patients based on

Give patients best care through participation in clinical trials

PHOENIX — Two speakers at Optometry’s Meeting urged optometrists to get involved in clinical trials to provide their patients with the best care.
Every drug that is prescribed and every device that is used started with a clinical trial, Roya Attar, OD, MBA, DHA, FAAO, FORS, associate professor and director of optometric services at University of Mississippi Medical Center, told attendees.
{{VIDEO}}
“The goal is to find better treatments to take care of our patients,” she said.
Clinical trials differ depending on the study design, such as interventional, observational, diagnostic, pragmatic,

Two investigational agents for wet AMD meet primary endpoints

Editor’s note: This is a developing news story. Please check back soon for updates.
Two investigational agents from Kodiak Sciences helped improve vision in patients with wet age-related macular degeneration, according to a press release.
In the phase 3 DAYBREAK study, researchers assessed Zenkuda (tarcocimab tedromer) and KSI-501 (tabirafusp alfa tedromer) vs. Eylea (aflibercept, Regeneron) in patients wet AMD. Zenkuda is an anti-VEGF that uses Kodiak’s antibody biopolymer conjugate (ABC) platform and is designed to maintain more durable drug levels. KSI-501 is an anti-IL-6, VEGF-trap